Skip to main content
Log in

Gain of 12p encompassing CCND2 is associated with gemistocytic histology in IDH mutant astrocytomas

  • Correspondence
  • Published:
Acta Neuropathologica Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Capper D, Sahm F, Hartmann C, Meyermann R, von Deimling A, Schittenhelm J (2010) Application of mutant IDH1 antibody to differentiate diffuse glioma from nonneoplastic central nervous system lesions and therapy-induced changes. Am J Surg Pathol 34:1199–1204

    Article  PubMed  Google Scholar 

  2. Chan JA, Zhang H, Roberts PS et al (2004) Pathogenesis of tuberous sclerosis subependymal giant cell astrocytomas: biallelic inactivation of TSC1 or TSC2 leads to mTOR activation. J Neuropathol Exp Neurol 63:1236–1242

    Article  CAS  PubMed  Google Scholar 

  3. Hoshino T, Wilson BC, Ellis WG (1975) Gemistocytic astrocytes in gliomas. An autoradiographic study. J Neuropathol Exp Neurol 34:263–281

    Article  CAS  PubMed  Google Scholar 

  4. Kros JM, Schouten WC, Janssen PJ, van der Kwast TH (1996) Proliferation of gemistocytic cells and glial fibrillary acidic protein (GFAP)-positive oligodendroglial cells in gliomas: a MIB-1/GFAP double labeling study. Acta Neuropathol 91:99–103

    Article  CAS  PubMed  Google Scholar 

  5. Krouwer HG, Davis RL, Silver P, Prados M (1991) Gemistocytic astrocytomas: a reappraisal. J Neurosurg 74:399–406

    Article  CAS  PubMed  Google Scholar 

  6. Lin YX, Lin K, Kang DZ et al (2015) Similar PDK1-AKT-mTOR pathway activation in balloon cells and dysmorphic neurons of type II focal cortical dysplasia with refractory epilepsy. Epilepsy Res 112:137–149

    Article  CAS  PubMed  Google Scholar 

  7. Louis DN, Perry A, Reifenberger G et al (2016) The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol 131:803–820

    Article  PubMed  Google Scholar 

  8. Mirzaa GM, Parry DA, Fry AE et al (2014) De novo CCND2 mutations leading to stabilization of cyclin D2 cause megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome. Nat Genet 46:510–515

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Ohta T, Kim YH, Oh JE et al (2014) Alterations of the RRAS and ERCC1 genes at 19q13 in gemistocytic astrocytomas. J Neuropathol Exp Neurol 73:908–915

    Article  CAS  PubMed  Google Scholar 

  10. Okamoto Y, Di Patre PL, Burkhard C et al (2004) Population-based study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomas. Acta Neuropathol 108:49–56

    Article  PubMed  Google Scholar 

  11. Peraud A, Ansari H, Bise K, Reulen HJ (1998) Clinical outcome of supratentorial astrocytoma WHO grade II. Acta Neurochir (Wien) 140:1213–1222

    Article  CAS  Google Scholar 

  12. Peraud A, Kreth FW, Wiestler OD, Kleihues P, Reulen HJ (2002) Prognostic impact of TP53 mutations and P53 protein overexpression in supratentorial WHO grade II astrocytomas and oligoastrocytomas. Clin Cancer Res Off J Am Assoc Cancer Res 8:1117–1124

    CAS  Google Scholar 

  13. Sahm F, Schrimpf D, Jones DT, Meyer J, Kratz A, Reuss D et al (2016) Next-generation sequencing in routine brain tumor diagnostics enables an integrated diagnosis and identifies actionable targets. Acta Neuropathol 131(6):903–910

    Article  CAS  PubMed  Google Scholar 

  14. Sturm D, Witt H, Hovestadt V et al (2012) Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. Cancer Cell 22:425–437

    Article  CAS  PubMed  Google Scholar 

  15. Walker AJ, Wedam S, Amiri-Kordestani L et al (2016) FDA approval of palbociclib in combination with fulvestrant for the treatment of hormone receptor-positive, HER2-negative metastatic breast cancer. Clin Cancer Res Off J Am Assoc Cancer Res 22:4968–4972

    Article  CAS  Google Scholar 

  16. Watanabe K, Peraud A, Gratas C, Wakai S, Kleihues P, Ohgaki H (1998) p53 and PTEN gene mutations in gemistocytic astrocytomas. Acta Neuropathol 95:559–564

    Article  CAS  PubMed  Google Scholar 

  17. Watanabe K, Tachibana O, Yonekawa Y, Kleihues P, Ohgaki H (1997) Role of gemistocytes in astrocytoma progression. Lab Invest 76:277–284

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Felix Sahm or Andreas von Deimling.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sahm, F., Korshunov, A., Schrimpf, D. et al. Gain of 12p encompassing CCND2 is associated with gemistocytic histology in IDH mutant astrocytomas. Acta Neuropathol 133, 325–327 (2017). https://doi.org/10.1007/s00401-016-1657-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00401-016-1657-7

Keywords

Navigation